AME vs SER · P/E 30, rev $7.40B vs rev $56.0K
Ametek Inc (AME) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
AME currently screens at market cap $42.11B and trailing P/E 29.9. SER currently screens at market cap $29.7M.
Not investment advice. Open the AME and SER stock pages for the full models.
Not investment advice.